Akebia Therapeutics reported $187.96M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 125.63M 9.06M
Agios Pharmaceuticals AGIO:US USD 62.63M 9.03M
Alnylam Pharmaceuticals ALNY:US USD 767.92M 4.88M
Amgen AMGN:US USD 15.69B 1.36B
Ardelyx ARDX:US USD 65.6M 13.65M
Astellas Pharma 4503:JP JPY 705.91B 55.51B
AstraZeneca AZN:LN USD 26.29B 1.44B
Avrobio Inc AVRO:US USD 16.19M 3.41M
Bayer BAYN:GR EUR 35.08B 1.91B
Biomarin Pharmaceutical BMRN:US USD 588.88M 67.86M
Exelixis EXEL:US USD 324.36M 22.63M
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Intercept Pharmaceuticals ICPT:US USD 230.08M 8.49M
Ironwood Pharmaceuticals IRWD:US USD 25.52M 1.59M
Karyopharm Therapeutics KPTI:US USD 72M 10.24M
Lexicon Pharmaceuticals LXRX:US USD 23.17M 4.73M
Moderna Inc MRNA:US USD 4.92B 1.88B
Nektar Therapeutics NKTR:US USD 68.2M 15.78M
Opko Health OPK:US USD 213.5M 53.77M
Prothena PRTA:US USD 50.15M 451K
Ptc Therapeutics PTCT:US USD 406.24M 13.84M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Roche Holding ROG:VX 27.24B 170M
Sarepta Therapeutics SRPT:US USD 619.6M 16.69M
Seattle Genetics SGEN:US USD 818.4M 92.41M
Vanda Pharmaceuticals VNDA:US USD 91.44M 1.19M